A detailed history of Ubs Group Ag transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Ubs Group Ag holds 127,791 shares of BHC stock, worth $944,375. This represents 0.0% of its overall portfolio holdings.

Number of Shares
127,791
Previous 204,785 37.6%
Holding current value
$944,375
Previous $1.43 Million 27.05%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$5.22 - $8.26 $401,908 - $635,970
-76,994 Reduced 37.6%
127,791 $1.04 Million
Q2 2024

Aug 13, 2024

BUY
$6.1 - $10.41 $424,993 - $725,275
69,671 Added 51.56%
204,785 $1.43 Million
Q1 2024

May 13, 2024

BUY
$7.77 - $10.61 $30,567 - $41,739
3,934 Added 3.0%
135,114 $1.43 Million
Q4 2023

Feb 09, 2024

SELL
$6.53 - $8.23 $1.72 Million - $2.16 Million
-263,052 Reduced 66.73%
131,180 $1.05 Million
Q3 2023

Nov 09, 2023

BUY
$7.69 - $9.71 $2.62 Million - $3.31 Million
341,213 Added 643.57%
394,232 $3.24 Million
Q2 2023

Aug 11, 2023

SELL
$5.72 - $8.8 $25.2 Million - $38.7 Million
-4,399,682 Reduced 98.81%
53,019 $424,000
Q1 2023

May 12, 2023

SELL
$6.28 - $9.85 $1.48 Million - $2.33 Million
-236,376 Reduced 5.04%
4,452,701 $36.1 Million
Q4 2022

Feb 08, 2023

BUY
$6.09 - $7.93 $15.6 Million - $20.4 Million
2,568,183 Added 121.09%
4,689,077 $29.4 Million
Q3 2022

Nov 10, 2022

BUY
$4.58 - $9.21 $7.88 Million - $15.8 Million
1,720,637 Added 429.88%
2,120,894 $14.6 Million
Q2 2022

Aug 10, 2022

BUY
$7.06 - $23.63 $1.52 Million - $5.1 Million
215,902 Added 117.11%
400,257 $3.35 Million
Q1 2022

May 16, 2022

SELL
$21.6 - $27.79 $394,826 - $507,973
-18,279 Reduced 9.02%
184,355 $4.21 Million
Q4 2021

Feb 14, 2022

SELL
$23.0 - $29.01 $5.1 Million - $6.43 Million
-221,664 Reduced 52.24%
202,634 $5.6 Million
Q3 2021

Nov 15, 2021

BUY
$25.04 - $30.06 $3.19 Million - $3.83 Million
127,424 Added 42.92%
424,298 $11.8 Million
Q2 2021

Aug 13, 2021

SELL
$27.43 - $32.7 $388,216 - $462,803
-14,153 Reduced 4.55%
296,874 $8.71 Million
Q1 2021

May 12, 2021

SELL
$21.37 - $34.38 $74,303 - $119,539
-3,477 Reduced 1.11%
311,027 $9.87 Million
Q4 2020

Feb 11, 2021

SELL
$15.31 - $21.12 $838,498 - $1.16 Million
-54,768 Reduced 14.83%
314,504 $6.54 Million
Q3 2020

Nov 12, 2020

BUY
$14.88 - $20.13 $1.65 Million - $2.23 Million
110,873 Added 42.91%
369,272 $5.74 Million
Q2 2020

Jul 31, 2020

SELL
$13.31 - $20.51 $1.78 Million - $2.74 Million
-133,440 Reduced 34.05%
258,399 $4.73 Million
Q1 2020

May 01, 2020

SELL
$12.98 - $30.25 $868,699 - $2.02 Million
-66,926 Reduced 14.59%
391,839 $6.07 Million
Q4 2019

Feb 14, 2020

SELL
$18.89 - $31.89 $516,717 - $872,319
-27,354 Reduced 5.63%
458,765 $13.7 Million
Q3 2019

Nov 14, 2019

BUY
$20.88 - $25.66 $975,450 - $1.2 Million
46,717 Added 10.63%
486,119 $10.6 Million
Q2 2019

Aug 14, 2019

BUY
$20.52 - $26.45 $2.49 Million - $3.21 Million
121,521 Added 38.23%
439,402 $11.1 Million
Q1 2019

May 14, 2019

SELL
$20.23 - $26.29 $2.43 Million - $3.15 Million
-119,923 Reduced 27.39%
317,881 $7.85 Million
Q4 2018

Feb 14, 2019

BUY
$17.64 - $28.32 $3.79 Million - $6.08 Million
214,822 Added 96.34%
437,804 $8.09 Million
Q3 2018

Nov 14, 2018

BUY
$20.64 - $25.67 $4.6 Million - $5.72 Million
222,982 New
222,982 $5.72 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.